GGrantIndex
← Leaderboards

Alison Motsinger-Reif

National Institute Of Environmental Health Sciences

$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding mix

By agency

By mechanism

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Collaborations

Research focus

CollaborationsGeneticResponseGenesGenome Wide Association StudyUniversitiesCohortGenetic VariantVariantMethod DevelopmentData SetBaseResearch PersonnelNational Institute Of Environmental Health SciencesDiabetes MellitusNon-Insulin-Dependent Diabetes MellitusMetabolomicsTraitParticipantPharmacogenomicsIndexingCardiovascular DiseasesPharmaceutical PreparationsMethodology

Grant awards (37)

Collaborative Applied Statistics$1,583,098
ZIA · FY2025 · ES · contact PI
The Personalized Environment and Genes Study$1,195,745
ZIA · FY2025 · ES · contact PI
Methods development for "Omics" data$639,976
ZIA · FY2025 · ES · contact PI
Statistical Genetics of Outcomes and Drug Response in Patients with Type 2 Diabetes.$336,829
ZIA · FY2025 · ES · contact PI
Exposomics Ancillary Study in All of Us$84,207
ZIA · FY2025 · ES · contact PI
EEOH Ancillary Study in All of Us$33,683
ZIA · FY2025 · ES · contact PI
Collaborative Applied Statistics$1,521,394
ZIA · FY2024 · ES · contact PI
The Personalized Environment and Genes Study$1,200,210
ZIA · FY2024 · ES · contact PI
Methods development for "Omics" data$912,836
ZIA · FY2024 · ES · contact PI
Statistical Genetics of Outcomes and Drug Response in Patients with Type 2 Diabetes.$338,087
ZIA · FY2024 · ES · contact PI
Statistical Genetics of Dose Response Traits$135,235
ZIA · FY2024 · ES · contact PI
Exposomics Ancillary Study in All of Us$84,522
ZIA · FY2024 · ES · contact PI
Collaborative Applied Statistics$1,391,771
ZIA · FY2023 · ES · contact PI
COVID-19 Pandemic Vulnerability$1,109,655
ZIA · FY2023 · ES · contact PI
Methods development for "Omics" data$1,015,616
ZIA · FY2023 · ES · contact PI
The Personalized Environment and Genes Study$338,539
ZIA · FY2023 · ES · contact PI
Statistical Genetics of Outcomes and Drug Response in Patients with Type 2 Diabetes.$150,462
ZIA · FY2023 · ES · contact PI
Statistical Genetics of Dose Response Traits$131,654
ZIA · FY2023 · ES · contact PI
Collaborative Applied Statistics$1,287,883
ZIA · FY2022 · ES · contact PI
COVID-19 Pandemic Vulnerability$999,804
ZIA · FY2022 · ES · contact PI
Methods development for "Omics" data$847,292
ZIA · FY2022 · ES · contact PI
Statistical Genetics of Outcomes and Drug Response in Patients with Type 2 Diabetes.$135,567
ZIA · FY2022 · ES · contact PI
Statistical Genetics of Dose Response Traits$118,621
ZIA · FY2022 · ES · contact PI
Collaborative Applied Statistics$2,199,004
ZIA · FY2021 · ES · contact PI
Methods development for "Omics" data$879,602
ZIA · FY2021 · ES · contact PI
Statistical Genetics of Outcomes and Drug Response in Patients with Type 2 Diabetes.$513,101
ZIA · FY2021 · ES · contact PI
COVID-19 Pandemic Vulnerability$458,126
ZIA · FY2021 · ES · contact PI
Statistical Genetics of Dose Response Traits$128,275
ZIA · FY2021 · ES · contact PI
Methods development for "Omics" data$803,886
ZIA · FY2020 · ES · contact PI
Collaborative Applied Statistics$703,400
ZIA · FY2020 · ES · contact PI
Statistical Genetics of Outcomes and Drug Response in Patients with Type 2 Diabetes.$562,720
ZIA · FY2020 · ES · contact PI
Statistical Genetics of Dose Response Traits$502,429
ZIA · FY2020 · ES · contact PI
COVID-19 Pandemic Vulnerability$381,846
ZIA · FY2020 · ES · contact PI
Statistical Genetics of Dose Response Traits$706,749
ZIA · FY2019 · ES · contact PI
Statistical Genetics of Outcomes and Drug Response in Patients with Type 2 Diabetes.$424,049
ZIA · FY2019 · ES · contact PI
Methods development for "Omics" data$353,374
ZIA · FY2019 · ES · contact PI
Collaborative Applied Statistics$282,699
ZIA · FY2019 · ES · contact PI